Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.03 |
| peg ratio | -0.00 |
| price to book ratio | -0.04 |
| price to sales ratio | 0.00 |
| enterprise value multiple | 0.60 |
| price fair value | -0.04 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -174.26% |
| return on equity | 87.31% |
| return on capital employed | -76.12% |
liquidity ratios | |
|---|---|
| current ratio | 31.15 |
| quick ratio | 31.15 |
| cash ratio | 10.57 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 13,596.25 |
| cash conversion cycle | -13,596.25 |
| receivables turnover | 0.00 |
| payables turnover | 0.03 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | -0.02 |
| long term debt to capitalization | -0.02 |
| total debt to capitalization | -0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -51.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -350.26 |
| cash per share | 1,142.78 |
| operating cash flow per share | -348.50 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -51.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -197.75 |
Frequently Asked Questions
When was the last time Vor Biopharma Inc. (NASDAQ:VOR) reported earnings?
Vor Biopharma Inc. (VOR) published its most recent earnings results on 13-05-2026.
What is Vor Biopharma Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vor Biopharma Inc. (NASDAQ:VOR)'s trailing twelve months ROE is 87.31%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vor Biopharma Inc. (VOR) currently has a ROA of -174.26%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VOR's net profit margin stand at?
VOR reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VOR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 31.15 in the most recent quarter. The quick ratio stood at 31.15, with a Debt/Eq ratio of -0.02.